Drugs in MeSH Category Cytochrome P-450 CYP2C19 Inducers
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sanofi Aventis Us | RIFADIN | rifampin | CAPSULE;ORAL | 050420-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | See Plans and Pricing | See Plans and Pricing | See Plans and Pricing | ||||
Epic Pharma | RIFAMPIN | rifampin | CAPSULE;ORAL | 064150-002 | Jan 2, 1998 | AB | RX | No | No | See Plans and Pricing | See Plans and Pricing | See Plans and Pricing | |||
Akorn | RIFAMPIN | rifampin | CAPSULE;ORAL | 065028-002 | Mar 14, 2001 | AB | RX | No | No | See Plans and Pricing | See Plans and Pricing | See Plans and Pricing | |||
Epic Pharma | RIFAMPIN | rifampin | CAPSULE;ORAL | 064150-001 | May 28, 1997 | AB | RX | No | No | See Plans and Pricing | See Plans and Pricing | See Plans and Pricing | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |